Lipocine Inc. (LPCN): Depreciation & Amortization
$60.8K
Year ended 2025-12-31
$58.6K
Trailing 12 months to 2026-06-30
+86.0%
3-year compound annual growth
+76.4%
5-year compound annual growth
+8.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $60.8K | +47.9% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $41.1K | +43.4% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $28.7K | +203.2% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $9.5K | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $380 | -89.3% | 2023-03-10, From 2021-01-01 |
| 2020-12-31 | $3.6K | -77.0% | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | $15.4K | -17.0% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $18.6K | -34.5% | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | $28.4K | -11.2% | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | $32.0K | +19.6% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $26.7K | +82.8% | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | $14.6K | -32.8% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $21.8K | -48.9% | 2015-03-11, From 2013-01-01 |
| 2012-12-31 | $42.6K | n/a | 2014-03-31, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Lipocine Inc. (LPCN) | 2025-12-31 | $60.8K | +47.9% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $235 | -74.2% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $900.0K | -12.5% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $68.8K | -27.9% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $70.0K | n/m |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $2.06M | +18.3% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $188.0K | +111.2% |
| Cannapharmarx, Inc. (CPMD) | 2024-12-31 | $0 | -100.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $384.0K | -24.6% |
Compare LPCN, BIOE, RANI, GOVX side by side · Screen every company in Pharmaceutical Preparations ↗